Tao and his colleagues reported that effector B cells directly killed tumor cells via the Fas/FasL and CXCR4/CXCL12 pathways, and the killing activities can be improved by IL-2 and inhibited by IL-10 [44–49]. Here, FAS is linked to neoplasm.